Meta-analysis of published studies or meta-analysis of individual data? Caesarean section in HIV-positive women as a study case

Public Health

Volumn 117, Issue 5, 2003, Pages 323-328

  Angelillo, I F ^a   Villari, Paolo ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Caesarean section; HIV infection; Meta analysis; Observational cohort studies; Pooled analysis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; WOMENS HEALTH;

ARTICLE; CESAREAN SECTION; DELIVERY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MEDICAL LITERATURE; META ANALYSIS; PATIENT CODING; PATIENT INFORMATION; PERINATAL INFECTION; PUBLIC HEALTH; PUBLICATION; RESOURCE MANAGEMENT; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION;

EID: 0041919607     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(03)00105-7     Document Type: Article

References (28)

1. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998;316: 140-4.
2. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999;28: 1-9.
3. Steinberg KK, Smith SJ, Stroup DF, et al. Comparison of effect estimates for a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. Am J Epidemiol 1997;145:917-25.
4. Stewart LA, Parmar MKB. Meta-analysis of the literature or of the individual patient data: is there a difference? Lancet 1993;341:418-22.
5. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA 1995;274:830-6.
6. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med 1999;340:977-87.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
8. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of diseases. J Natl Cancer Inst 1959;22:719-48.
9. Hutto C, Parks WP, Lai S, et al. A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr 1991;118:347-53.
10. Lindgren S, Anzen B, Bohlin AB, Lidman K. HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. AIDS 1991;5:1111-6.
11. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994;271:1925-30.
12. Burns DN, Landesman S, Muenz LR, et al. Cigarette smoking, premature rupture of membranes and vertical transmission of HIV-1 among women with low CD4 + levels. J AIDS 1994; 7:718-26.
13. European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996; 10:1675-81.
14. Tovo PA, de Martino M, Gabiano C, The Italian Register for HIV Infection in Children, et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. J AIDS 1996;11:88-94.
15. Maguire A, Sanchez E, Fortuny C, Casabona J, The Working Group on HIV-1 Vertical Transmission in Catalonia. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section. AIDS 1997;11: 1851-7.
16. Simpson BJ, Shapiro ED, Andiman WA. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J AIDS 1997;14:145-52.
17. For The French Perinatal Cohort:Mandelbrot L, Le Chenadec J, Barrebi A, et al. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 1998;280:55-60.
18. Kind C, Rudin C, Siegrist CA, The Swiss Neonatal HIV Study Group, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS 1998;12:205-10.
19. 2 HIV Study: the role of EBV shedding. J AIDS 1998;19:462-70.
20. For The Perinatal AIDS Collaborative Transmission Studies: Simonds RJ, Steketee R, Nesheim S, et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. AIDS 1998;12:301-8.
21. For The Women and Infants Transmission Study Group:Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999;341:394-402.
22. For The Bangkok Collaborative Perinatal HIV Transmission Study Group:Shaffer N, Roongpisuthipong A, Siriwasin W, et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. J Infect Dis 1999;179:590-9.
23. Van Dyke RB, Korber BT, Popek E, The Ariel Core Investigators, et al. The Ariel Project: a prospective cohort study of maternal - child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy. J Infect Dis 1999;179:319-28.
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50: 1088-99.
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315: 629-34.
26. The European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343:1464-7.
27. Villari P, Spino C, Chalmers TC, Lau J, Sacks HS. Cesarean section to reduce perinatal transmission of human immunodeficiency virus. Online J Curr Clin Trials 8 Jul 1993;74.
28. The European Mode of Delivery Collaboration. Elective caesarean-section vs vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999;353:1035-9.